Zur Kurzanzeige

2013-08-15Zeitschriftenartikel DOI: 10.1186/1471-2334-13-375
Co-infection of human parvovirus B19 with Plasmodium falciparum contributes to malaria disease severity in Gabonese patients
dc.contributor.authorToan, Nguyen Linh
dc.contributor.authorSy, Bui Tien
dc.contributor.authorSong, Le Huu
dc.contributor.authorLuong, Hoang Van
dc.contributor.authorBinh, Nguyen T.
dc.contributor.authorBinh, Vu Q.
dc.contributor.authorKandolf, Reinhard
dc.contributor.authorVelavan, Thirumalaisamy P.
dc.contributor.authorKremsner, Peter G.
dc.contributor.authorBock, Thomas
dc.date.accessioned2018-05-07T17:01:04Z
dc.date.available2018-05-07T17:01:04Z
dc.date.created2013-09-13
dc.date.issued2013-08-15none
dc.identifier.otherhttp://edoc.rki.de/oa/articles/rerPmKn1CpuY/PDF/20useF5oIKA2.pdf
dc.identifier.urihttp://edoc.rki.de/176904/1663
dc.description.abstractBackground: High seroprevalence of parvovirus B19 (B19V) coinfection with Plasmodium falciparum has been previously reported. However, the impact of B19V-infection on the clinical course of malaria is still elusive. In this study, we investigated the prevalence and clinical significance of B19V co-infection in Gabonese children with malaria. Methods: B19V prevalence was analyzed in serum samples of 197 Gabonese children with P. falciparum malaria and 85 healthy controls using polymerase chain reaction (PCR), enzyme-linked immunosorbent assay (ELISA), and direct DNA-sequencing. Results: B19V was detected in 29/282 (10.28%) of Gabonese children. B19V was observed more frequently in P. falciparum malaria patients (14.21%) in comparison to healthy individuals (1.17%) (Peng
dc.language.isoeng
dc.publisherRobert Koch-Institut
dc.subjectMalariaeng
dc.subjectErythroviruseng
dc.subjectHuman parvovirus B19eng
dc.subjectP. falciparumeng
dc.subjectCo-infectioneng
dc.subjectGabonese childreneng
dc.subject.ddc610 Medizin
dc.titleCo-infection of human parvovirus B19 with Plasmodium falciparum contributes to malaria disease severity in Gabonese patients
dc.typeperiodicalPart
dc.identifier.urnurn:nbn:de:0257-10032770
dc.identifier.doi10.1186/1471-2334-13-375
dc.identifier.doihttp://dx.doi.org/10.25646/1588
local.edoc.container-titleBMC Infectious Diseases
local.edoc.fp-subtypeArtikel
local.edoc.type-nameZeitschriftenartikel
local.edoc.container-typeperiodical
local.edoc.container-type-nameZeitschrift
local.edoc.container-urlhttp://www.biomedcentral.com/1471-2334/13/375/abstract
local.edoc.container-publisher-nameBioMedCentral
local.edoc.container-volume13
local.edoc.container-issue375
local.edoc.container-year2013

Zur Kurzanzeige